**US4595061015 - Common Stock **

Taking everything into account, **IFF** scores **2** out of 10 in our fundamental rating. **IFF** was compared to 122 industry peers in the **Chemicals** industry. Both the profitability and financial health of **IFF** have multiple concerns. While showing a medium growth rate, **IFF** is valued expensive at the moment.

*Note: IFF has only limited data available, so a full analysis was not possible, which makes the total rating unfair.*

When comparing the price book ratio of **IFF** to the average industry price book ratio of 2.20, **IFF** is valued rather cheaply.

The **Price/Earnings Ratio** is **20.05**, which indicates a rather expensive current valuation of **IFF**.

With a **Forward Price/Earnings Ratio** of **19.39**, **IFF** is valued rather expensively.

With a price book ratio of **1.72**, **IFF** is valued correctly.

Compared to an average industry **Price/Earning Ratio** of **13.22**, **IFF** is valued slightly more expensive.

The high **PEG Ratio**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

Compared to an average industry **Enterprise Value to EBITDA** ratio of 9.24, **IFF** is valued more expensive than its industry peers. **83%** of the companies listed in the same industry are valued cheaper.

Price/Earnings (20.05) VS Industry: 26% outperformed.

606.52

1.93

Price/Book (1.72) VS Industry: 65% outperformed.

764.36

0.03

Enterprise Value/ EBITDA (16.84) VS Industry: 17% outperformed.

13,692.96

1.59

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

Looking at the last year, **IFF** shows a very strong growth in **Revenue**. The Revenue has grown by **27.61%**.

The **Revenue** has been growing by **30.19%** on average over the past 5 years. This is a very strong growth!

Measured over the past 5 years, **IFF** shows a small growth in **Earnings Per Share**. The EPS has been growing by **0.61%** on average per year.

Based on estimates for the next 5 years, **IFF** will show a small growth in **Earnings Per Share**. The EPS will grow by **8.19%** on average per year.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | 0.61% | -2.99% | -3.4% | -0.52% | 1.87% | 5.42% | 8.19% |

Revenue | 30.19% | 43.1% | 27.61% | 7.72% | 4.34% | 4.44% | 4.79% |

The Debt to Equity ratio of **IFF** is in line with the industry averages.

The Piotroski-F score of **IFF** is **4.00**. This is a neutral score and indicates average health and profitability for **IFF**.

Compared to an average industry Current Ratio of 2.12, **IFF** is worse placed to pay its short term obligations than its industry peers.

A Quick Ratio of **0.93** indicates that **IFF** may have some problems paying its short term obligations.

When comparing the Quick Ratio of **IFF** to the average industry Current Ratio of **1.33**, **IFF** is less able to pay its short term obligations than its industry peers.

Based on the Altman-Z score of **1.60**, we must say that **IFF** is in the distress zone and has some risk of bankruptcy.

Compared to an average industry Altman-Z score of **2.73**, **IFF** is in worse financial health than its industry peers.

Debt/Equity (0.61) VS Industry: 45% outperformed.

19.13

0.00

Quick Ratio (0.93) VS Industry: 24% outperformed.

0.01

65.94

Current Ratio (1.79) VS Industry: 39% outperformed.

0.01

65.94

Altman-Z (1.6) VS Industry: 23% outperformed.

-529.45

147.59

Compared to an average industry **Dividend Yield** of **2.22**, **IFF** pays a bit more dividend than its industry peers.

Compared to an average S&P500 **Dividend Yield** of **2.41**, **IFF** has a dividend comparable with the average S&P500 company.

The dividend of **IFF** has a limited annual growth rate of **3.45%**.

The earnings of **IFF** are negative and hence is the payout ratio. **IFF** will probably not be able to sustain this dividend level.

Dividend Yield (2.88%) VS Industry: 61% outperformed.

0.30

22.94

NYSE:IFF (2/2/2023, 8:36:08 AM)**+0.59 (+0.52%) **

GICS Sector | Materials | ||

GICS IndustryGroup | Materials | ||

GICS Industry | Chemicals | ||

Earnings (Last) | 11-07 2022-11-07/amc | Earnings (Next) | 02-07 2023-02-07 |

Inst Owners | 87.12% | Inst Owner Change | 0.23% |

Ins Owners | 0.05% | Ins Owner Change | -1.93% |

Market Cap | 29.09B | Analysts | 74.62 |

Price Target | 125.58 (10.06%) |

Dividend Yield | 2.88% | Dividend Growth | 3.45% |

DP | -45.9% | Ex-Date | N/A |

EPS beat(2) | 2 | Avg EPS beat(2) | 3.97% |

Min EPS beat(2) | 2.29% | Max EPS beat(2) | 5.66% |

EPS beat(4) | 4 | Avg EPS beat(4) | 9.19% |

Min EPS beat(4) | 2.29% | Max EPS beat(4) | 23.62% |

Revenue beat(2) | 1 | Avg Revenue beat(2) | -0.2% |

Min Revenue beat(2) | -1.38% | Max Revenue beat(2) | 0.98% |

Revenue beat(4) | 3 | Avg Revenue beat(4) | 1.2% |

Min Revenue beat(4) | -1.38% | Max Revenue beat(4) | 3.03% |

PT rev (1m) | 1.61% | PT rev (3m) | -9.19% |

EPS NQ rev (1m) | 0% | EPS NQ rev (3m) | -13.64% |

EPS NY rev (1m) | 0% | EPS NY rev (3m) | -0.9% |

Revenue NQ rev (1m) | 0% | Revenue NQ rev (3m) | -5.54% |

Revenue NY rev (1m) | 0% | Revenue NY rev (3m) | -1.55% |

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 20.05 | ||

Fwd PE | 19.39 | ||

P/S | 2.3 | ||

P/FCF | 9697.45 | ||

P/OCF | 58.18 | ||

P/B | 1.72 | ||

P/tB | N/A | ||

EV/EBITDA | 16.84 |

EPS(TTM) | 5.69 | EY | 4.99% |

EPS(NY) | 5.88 | Fwd EY | 5.16% |

FCF(TTM) | 0.01 | FCFY | 0.01% |

OCF(TTM) | 1.96 | OCFY | 1.72% |

SpS | 49.53 | BVpS | 66.23 |

TBVpS | -22.76 | PEG (NY) | N/A |

PEG (5Y) | 32.84 |

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | N/A | ||

ROE | N/A | ||

ROIC | 2.92% | ||

ROICexc | 2.97% | ||

ROICexgc | 11.52% | ||

OM | 8.89% | ||

PM | N/A | ||

GM | 33.76% |

ROICexgc(3y) | 14.63% | ROICexcg growth 3Y | -30.89% |

ROICexcg growth 5Y | -28.31% | ROICexc(3y) | 3.61% |

ROICexc growth 3Y | -30.76% | ROICexc growth 5Y | -38.13% |

OM growth 3Y | -28.68% | OM growth 5Y | -20.93% |

PM growth 3Y | -35.03% | PM growth 5Y | -29.24% |

GM growth 3Y | -8.84% | GM growth 5Y | -6.48% |

F-Score | 4 | Asset Turnover | 0.37 |

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.61 | ||

Debt/FCF | 3592.67 | ||

Debt/EBITDA | 4.66 | ||

Cap/Depr | 41.69% | ||

Profit Quality | N/A | ||

Current Ratio | 1.79 | ||

Quick Ratio | 0.93 | ||

Altman-Z | 1.6 |

F-Score | 4 | WACC | 8.92% |

ROIC/WACC | 1.29 | Cap/Depr(3y) | 56.05% |

Cap/Depr(5y) | 75.45% | Profit Quality(3y) | 211.3% |

Profit Quality(5y) | 160.39% |

EPS 1Y | -3.4% | EPS 3Y | -2.99% |

EPS 5Y | 0.61% | EPS growth Q2Q | -7.48% |

EPS Next Y | -0.52% | EPS Next 2Y | 1.87% |

EPS Next 3Y | 5.42% | EPS Next 5Y | 8.19% |

Revenue growth 1Y | 27.61% | Revenue growth 3Y | 43.1% |

Revenue growth 5Y | 30.19% | Revenue growth Q2Q | -0.26% |

Revenue Next Year | 7.72% | Revenue Next 2Y | 4.34% |

Revenue Next 3Y | 4.44% | Revenue Next 5Y | 4.79% |

EBIT growth 1Y | 101.51% | EBIT growth 3Y | 2.07% |

EBIT growth 5Y | 2.95% | EBIT Next Year | 33.35% |

EBIT Next 3Y | 14.72% | EBIT Next 5Y | 12.19% |

FCF growth 1Y | -99.44% | FCF growth 3Y | 57.89% |

FCF growth 5Y | 19.67% | OCF growth 1Y | -31.6% |

OCF growth 3Y | 48.64% | OCF growth 5Y | 21.17% |

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*